Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1986 1
1994 1
2001 1
2004 6
2005 39
2006 46
2007 31
2008 17
2009 9
2010 7
2011 1
2013 1
2014 1
2016 1
2017 2
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 17296963

160 results
Results by year
Filters applied: . Clear all
Page 1
Cardiac risks with COX-2 inhibitors.
Ashworth AJ. Ashworth AJ. CMAJ. 2007 Feb 13;176(4):489-92. doi: 10.1503/cmaj.1060144. CMAJ. 2007. PMID: 17296963 Free PMC article. No abstract available.
Balancing the cyclooxygenase portfolio.
Armstrong PW. Armstrong PW. CMAJ. 2006 May 23;174(11):1581-2. doi: 10.1503/cmaj.060471. CMAJ. 2006. PMID: 16717266 Free PMC article. No abstract available.
[Use of rofecoxib in family practice in the north of Netherlands, 2000-2004: background and consequences].
van der Veen WJ, van der Werf GT. van der Veen WJ, et al. Ned Tijdschr Geneeskd. 2006 May 6;150(18):1016-21. Ned Tijdschr Geneeskd. 2006. PMID: 16715866 Dutch.
COX-2 inhibitors and heart.
Manoria P, Manoria PC. Manoria P, et al. Indian Heart J. 2005 Nov-Dec;57(6):772-7. Indian Heart J. 2005. PMID: 16521658 Review. No abstract available.
[Assessment and truth -- how many cardio- and cerebrovascular events are in fact to be led back to taking rofecoxib].
Mühlbauer B, Timm J. Mühlbauer B, et al. Med Klin (Munich). 2006 Aug 15;101(8):673-5; author reply 678-9. Med Klin (Munich). 2006. PMID: 17051669 German. No abstract available.
Persistence of cardiovascular risk after rofecoxib discontinuation.
Ross JS, Madigan D, Konstam MA, Egilman DS, Krumholz HM. Ross JS, et al. Arch Intern Med. 2010 Dec 13;170(22):2035-6. doi: 10.1001/archinternmed.2010.461. Arch Intern Med. 2010. PMID: 21149763 Free PMC article. No abstract available.
The withdrawal of rofecoxib.
Arellano FM. Arellano FM. Pharmacoepidemiol Drug Saf. 2005 Mar;14(3):213-7. doi: 10.1002/pds.1077. Pharmacoepidemiol Drug Saf. 2005. PMID: 15724267 No abstract available.
COX-2 inhibitors and the heart: putting risk in perspective.
Bobadilla RV, Barnett EM, Randels CL. Bobadilla RV, et al. Adv Nurse Pract. 2005 Nov;13(11):48-50. Adv Nurse Pract. 2005. PMID: 16295003 Review. No abstract available.
Clinical inquiries. Do COX-2 inhibitors worsen renal function?
Wall R, Strickland C, Jamieson B, Lo V. Wall R, et al. J Fam Pract. 2007 Nov;56(11):957-8. J Fam Pract. 2007. PMID: 17976347 No abstract available.
[How many harmed by rofecoxib in Germany?].
Scharnetzky E, Andersohn F, Schill W, Garbe E, Pigeot I. Scharnetzky E, et al. Med Klin (Munich). 2006 Aug 15;101(8):675-6; author reply 678-9. Med Klin (Munich). 2006. PMID: 17051670 German. No abstract available.
160 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback